Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src

被引:25
作者
Cen, Bo [1 ]
Li, Haiyang [1 ]
Weinstein, I. Bernard [1 ,2 ]
机构
[1] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA
关键词
DEPENDENT KINASE INHIBITOR; ACTIVATED MAST-CELLS; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL ACTIVITY; PROGNOSTIC-SIGNIFICANCE; TYROSINE KINASE; CDK INHIBITORS; HUMAN CANCER; CYCLIN; P27;
D O I
10.1074/jbc.M804531200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The one or more underlying mechanisms of the tumor suppressing activity of the histidine triad nucleotide-binding protein 1 (HINT1) are not well defined. In this study we found that HINT1 regulates cellular levels of the cyclin-dependent kinase inhibitor p27(KIP1) through multiple mechanisms. Increased expression of HINT1 increases cellular levels of p27(KIP1), and HINT1 knockdown with small hairpin RNA leads to decreased cellular levels of p27(KIP1). HINT1 does not affect the transcription of p27(KIP1), but it does inhibit proteasomal degradation of the p27(KIP1) protein. HINT1 directly interacts with the SCFSKP2 ubiquitin ligase complex and inhibits the ubiquitylation of p27(KIP1). Src has been shown to phosphorylate p27(KIP1) and thus decrease its stability. We found that HINT1 is a negative regulator of Src transcription apparently by forming a complex with the transcription factor Sp1 on the promoter of Src. Taken together, our findings indicate that HINT1 up-regulates cellular levels of p27(KIP1) by two mechanisms: 1) it inhibits its ubiquitylation by targeting the SCFSKP2 ubiquitin ligase complex, and 2) it inhibits the phosphorylation of p27(KIP1) by Src via inhibiting Src expression.
引用
收藏
页码:5265 / 5276
页数:12
相关论文
共 53 条
[1]   RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling [J].
Ajit, Seena K. ;
Ramineni, Suneela ;
Edris, Wade ;
Hunt, Rachel A. ;
Hum, Wah-Tung ;
Hepler, John R. ;
Young, Kathleen H. .
CELLULAR SIGNALLING, 2007, 19 (04) :723-730
[2]   Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition [J].
Avizienyte, E ;
Fincham, VJ ;
Brunton, VG ;
Frame, MC .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (06) :2794-2803
[3]   CDK inhibitors: Cell cycle regulators and beyond [J].
Besson, Arnaud ;
Dowdy, Steven F. ;
Roberts, James M. .
DEVELOPMENTAL CELL, 2008, 14 (02) :159-169
[4]   Tyrosine kinase signalling in breast cancer - Epidermal growth factor receptor and c-Src interactions in breast cancer [J].
Biscardi, JS ;
Ishizawar, RC ;
Silva, CM ;
Parsons, SJ .
BREAST CANCER RESEARCH, 2000, 2 (03) :203-210
[5]   Deregulated degradation of the cdk inhibitor p27 and malignant transformation [J].
Bloom, J ;
Pagano, M .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (01) :41-47
[6]  
BONHAM K, 1993, ONCOGENE, V8, P1973
[8]  
Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO
[9]  
2-8
[10]   Regulation, substrates and functions of src [J].
Brown, MT ;
Cooper, JA .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :121-149